Bile acids upregulate BRCA1 and downregulate estrogen receptor 1 gene expression in ovarian cancer cells
暂无分享,去创建一个
[1] L. Salmena,et al. BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane , 2014, British Journal of Cancer.
[2] F. Berrino,et al. A randomized controlled trial of diet and physical activity in BRCA mutation carriers , 2014, Familial Cancer.
[3] D. Umpierre,et al. Incidence of Cancer Following Bariatric Surgery: Systematic Review and Meta-analysis , 2014, Obesity Surgery.
[4] W. Strodel,et al. A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass , 2013, Diabetes Care.
[5] Diana Eccles,et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. , 2013, Journal of the National Cancer Institute.
[6] Xiaohui Xie,et al. MotifMap: integrative genome-wide maps of regulatory motif sites for model species , 2011, BMC Bioinformatics.
[7] Denis Larsimont,et al. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation , 2007, Breast Cancer Research and Treatment.
[8] E. Rosen,et al. Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes , 2000, Journal of Molecular Medicine.
[9] J. Whang‐Peng,et al. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. , 1983, Cancer research.